Eosinophilic fasciitis induced by nivolumab therapy managed without treatment interruption or systemic immunosuppression

Eosinophilic fasciitis induced by nivolumab therapy managed without treatment interruption or systemic immunosuppression

Bibliographic Details
Main Authors: Ai-Tram N. Bui, BA, Caroline A. Nelson, MD, Christine G. Lian, MD, Alvaro Laga Canales, MD, MMSC, Nicole R. LeBoeuf, MD, MPH
Format: Article
Language:English
Published: Elsevier 2020-08-01
Series:JAAD Case Reports
Subjects:
autoimmunity
checkpoint inhibition
cutaneous toxicities
eosinophilic fasciitis
immune checkpoint inhibitors
immune-related adverse event
Online Access:http://www.sciencedirect.com/science/article/pii/S2352512620302800
id doaj-c85e2cd3454d49b186bd2e43c356d6c7
record_format Article
spelling doaj-c85e2cd3454d49b186bd2e43c356d6c72020-11-25T03:48:40ZengElsevierJAAD Case Reports2352-51262020-08-0168693696Eosinophilic fasciitis induced by nivolumab therapy managed without treatment interruption or systemic immunosuppressionAi-Tram N. Bui, BA0Caroline A. Nelson, MD1Christine G. Lian, MD2Alvaro Laga Canales, MD, MMSC3Nicole R. LeBoeuf, MD, MPH4Harvard Medical School, Boston, MassachusettsDepartment of Dermatology, Yale School of Medicine, New Haven, ConnecticutDepartment of Pathology, Brigham and Women's Hospital, Boston, MassachusettsDepartment of Pathology, Brigham and Women's Hospital, Boston, MassachusettsDepartment of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts; Correspondence to: Nicole R. LeBoeuf, MD, MPH, Dana-Farber/Brigham and Women's Cancer Center; Center for Cutaneous Oncology; 450 Brookline Avenue; Boston, MA 02115.http://www.sciencedirect.com/science/article/pii/S2352512620302800autoimmunitycheckpoint inhibitioncutaneous toxicitieseosinophilic fasciitisimmune checkpoint inhibitorsimmune-related adverse event
collection DOAJ
language English
format Article
sources DOAJ
author Ai-Tram N. Bui, BA
Caroline A. Nelson, MD
Christine G. Lian, MD
Alvaro Laga Canales, MD, MMSC
Nicole R. LeBoeuf, MD, MPH
spellingShingle Ai-Tram N. Bui, BA
Caroline A. Nelson, MD
Christine G. Lian, MD
Alvaro Laga Canales, MD, MMSC
Nicole R. LeBoeuf, MD, MPH
Eosinophilic fasciitis induced by nivolumab therapy managed without treatment interruption or systemic immunosuppression
JAAD Case Reports
autoimmunity
checkpoint inhibition
cutaneous toxicities
eosinophilic fasciitis
immune checkpoint inhibitors
immune-related adverse event
author_facet Ai-Tram N. Bui, BA
Caroline A. Nelson, MD
Christine G. Lian, MD
Alvaro Laga Canales, MD, MMSC
Nicole R. LeBoeuf, MD, MPH
author_sort Ai-Tram N. Bui, BA
title Eosinophilic fasciitis induced by nivolumab therapy managed without treatment interruption or systemic immunosuppression
title_short Eosinophilic fasciitis induced by nivolumab therapy managed without treatment interruption or systemic immunosuppression
title_full Eosinophilic fasciitis induced by nivolumab therapy managed without treatment interruption or systemic immunosuppression
title_fullStr Eosinophilic fasciitis induced by nivolumab therapy managed without treatment interruption or systemic immunosuppression
title_full_unstemmed Eosinophilic fasciitis induced by nivolumab therapy managed without treatment interruption or systemic immunosuppression
title_sort eosinophilic fasciitis induced by nivolumab therapy managed without treatment interruption or systemic immunosuppression
publisher Elsevier
series JAAD Case Reports
issn 2352-5126
publishDate 2020-08-01
topic autoimmunity
checkpoint inhibition
cutaneous toxicities
eosinophilic fasciitis
immune checkpoint inhibitors
immune-related adverse event
url http://www.sciencedirect.com/science/article/pii/S2352512620302800
work_keys_str_mv AT aitramnbuiba eosinophilicfasciitisinducedbynivolumabtherapymanagedwithouttreatmentinterruptionorsystemicimmunosuppression
AT carolineanelsonmd eosinophilicfasciitisinducedbynivolumabtherapymanagedwithouttreatmentinterruptionorsystemicimmunosuppression
AT christineglianmd eosinophilicfasciitisinducedbynivolumabtherapymanagedwithouttreatmentinterruptionorsystemicimmunosuppression
AT alvarolagacanalesmdmmsc eosinophilicfasciitisinducedbynivolumabtherapymanagedwithouttreatmentinterruptionorsystemicimmunosuppression
AT nicolerleboeufmdmph eosinophilicfasciitisinducedbynivolumabtherapymanagedwithouttreatmentinterruptionorsystemicimmunosuppression
_version_ 1724497717132001280

Similar Items